RLAY
Price
$4.19
Change
+$0.06 (+1.45%)
Updated
Sep 17, 02:43 PM (EDT)
Capitalization
699.99M
49 days until earnings call
TERN
Price
$7.61
Change
+$0.31 (+4.25%)
Updated
Sep 17, 03:05 PM (EDT)
Capitalization
623.95M
62 days until earnings call
Interact to see
Advertisement

RLAY vs TERN

Header iconRLAY vs TERN Comparison
Open Charts RLAY vs TERNBanner chart's image
Relay Therapeutics
Price$4.19
Change+$0.06 (+1.45%)
Volume$454
Capitalization699.99M
Terns Pharmaceuticals
Price$7.61
Change+$0.31 (+4.25%)
Volume$300
Capitalization623.95M
RLAY vs TERN Comparison Chart in %
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. TERN commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Buy and TERN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (RLAY: $4.13 vs. TERN: $7.30)
Brand notoriety: RLAY and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 52% vs. TERN: 71%
Market capitalization -- RLAY: $699.99M vs. TERN: $623.95M
RLAY [@Biotechnology] is valued at $699.99M. TERN’s [@Biotechnology] market capitalization is $623.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, RLAY is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 7 TA indicator(s) are bullish while TERN’s TA Score has 2 bullish TA indicator(s).

  • RLAY’s TA Score: 7 bullish, 4 bearish.
  • TERN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than TERN.

Price Growth

RLAY (@Biotechnology) experienced а +1.47% price change this week, while TERN (@Biotechnology) price change was -3.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was +6.99%, and the average quarterly price growth was +35.85%.

Reported Earning Dates

RLAY is expected to report earnings on Nov 05, 2025.

TERN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($700M) has a higher market cap than TERN($624M). TERN YTD gains are higher at: 31.769 vs. RLAY (0.243). TERN has higher annual earnings (EBITDA): -105M vs. RLAY (-338.15M). RLAY has more cash in the bank: 657M vs. TERN (315M). TERN has less debt than RLAY: TERN (1.13M) vs RLAY (34.2M). RLAY has higher revenues than TERN: RLAY (8.36M) vs TERN (0).
RLAYTERNRLAY / TERN
Capitalization700M624M112%
EBITDA-338.15M-105M322%
Gain YTD0.24331.7691%
P/E RatioN/AN/A-
Revenue8.36M0-
Total Cash657M315M209%
Total Debt34.2M1.13M3,019%
TECHNICAL ANALYSIS
Technical Analysis
RLAYTERN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 30 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNOCX33.80N/A
N/A
Easterly Snow Long/Short Opportunity C
JMCCX60.35N/A
N/A
JPMorgan Mid Cap Equity C
RAPCX11.10N/A
N/A
Cohen & Steers Real Assets C
NMAVX12.34N/A
N/A
Nuance Mid Cap Value Investor
MKVIX17.16N/A
N/A
MFS International Large Cap Value I